• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: October 2021

Pharma & Human Health

Probiotics : A Helping Hand Toward a Fitter Life

October 27, 2021 Microbiome Times

For a long time, consumers have associated metabolic health with a healthy weight, but it goes far beyond that. Metabolic health is not about looking good, it is about being healthy, and it involves having […]

Pharma & Human Health

New study characterizes the gut virome

October 25, 2021 Microbiome Times

A new study has added numerous previously uncharacterized viral genomes and genes to the ever-increasing worldwide pool of human gut viromes. The study, published in mSystems, an open-access journal of the American Society for Microbiology, […]

Pharma & Human Health

Solarea Bio Announces Licensing Agreement with ADM

October 20, 2021 Microbiome Times

Solarea Bio, a biotech company based in Cambridge, MA that is developing microbial-based solutions to aid human health, announced it has signed a technology licensing agreement with global nutrition leader ADM (NYSE: ADM). Solarea Bio has developed […]

Finance

Axial Therapeutics Raises $37.25 Million in Series C Financing

October 13, 2021 Microbiome Times

Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases, today announced the completion of a $37.25 million Series C financing. OneVentures, a venture capital firm headquartered in Sydney, […]

Finance

Framing the Narrative on CMC Development for Microbiome Therapeutics

October 12, 2021 Melanie Cerullo, Jeffrey Heiser and Aaron B Cowley

Nascent, Complex, and Evolving Market The microbial population in the human body the human microbiome numbers in the trillions,(1) and genes within these microbes are often referred to as the “second genome”(2). Most commensal, symbiotic, […]

Pharma & Human Health

Intralytix Receives FDA Regulatory Clearance for Phage-Based Campylobacter Technology

October 11, 2021 Microbiome Times

Intralytix, Inc. announced that its food safety product, CampyShield™, has received GRAS (Generally Recognized as Safe) recognition from the Food and Drug Administration (FDA), GRAS No: GRN 000966. CampyShield™ is a non-chemical antimicrobial preparation containing […]

Pharma & Human Health

Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA

October 5, 2021 Microbiome Times

Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that its Phase 2 clinical trial of VE303, an orally administered investigational live […]

Pharma & Human Health

Changing requirements for anaerobic culture equipment in microbiome research and product development

October 5, 2021 Microbiome Times

Improved growth of certain organisms (now known to be bacteria) in the absence of oxygen was conclusively demonstrated by Louis Pasteur in the 1860s.  Catalytic removal of oxygen from the incubation atmosphere, allowing surface growth […]

Pharma & Human Health

L’Oréal Singapore and NTU Singapore set up joint lab hosted by SCELSE for deeper exploration of skin and scalp microbiomes

October 4, 2021 Microbiome Times

Nanyang Technological University, Singapore (NTU Singapore) and L’Oréal Singapore today launched a new joint laboratory hosted by the Singapore Centre for Environmental Life Sciences Engineering (SCELSE), to conduct research on the community of bacteria, fungi, […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter